Biogaia AB
STO:BIOG B

Watchlist Manager
Biogaia AB Logo
Biogaia AB
STO:BIOG B
Watchlist
Price: 110.2 SEK 0.64% Market Closed
Market Cap: 11.1B SEK
Have any thoughts about
Biogaia AB?
Write Note

Relative Value

The Relative Value of one BIOG B stock under the Base Case scenario is 124.3 SEK. Compared to the current market price of 110.2 SEK, Biogaia AB is Undervalued by 11%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BIOG B Relative Value
Base Case
124.3 SEK
Undervaluation 11%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
53
vs Industry
47
Median 3Y
8.9
Median 5Y
8.3
Industry
7.6
Forward
7.9
vs History
30
vs Industry
5
Median 3Y
31.6
Median 5Y
27.6
Industry
22.1
Forward
31.7
vs History
50
vs Industry
6
Median 3Y
30.8
Median 5Y
28.3
Industry
21.9
vs History
52
vs Industry
4
Median 3Y
34.7
Median 5Y
31.3
Industry
23.4
vs History
6
vs Industry
15
Median 3Y
5.4
Median 5Y
5
Industry
2.5
vs History
44
vs Industry
41
Median 3Y
7.7
Median 5Y
7.1
Industry
7.5
Forward
7.1
vs History
49
vs Industry
34
Median 3Y
10.6
Median 5Y
9.7
Industry
9.3
vs History
44
vs Industry
5
Median 3Y
21.7
Median 5Y
20
Industry
4.2
Forward
22.6
vs History
34
vs Industry
5
Median 3Y
24.1
Median 5Y
21.3
Industry
4
Forward
25.4
vs History
47
vs Industry
6
Median 3Y
26.3
Median 5Y
24.7
Industry
5.9
vs History
44
vs Industry
4
Median 3Y
27.7
Median 5Y
26.3
Industry
3.9
vs History
33
vs Industry
19
Median 3Y
12.2
Median 5Y
11.2
Industry
4.5

Multiples Across Competitors

BIOG B Competitors Multiples
Biogaia AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Biogaia AB
STO:BIOG B
11.1B SEK 8.2 33.1 21 25.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 142 781.8 -181 287 -220 140.1 -217 628.1
US
Abbvie Inc
NYSE:ABBV
314.9B USD 5.7 62.1 15.4 23.7
US
Amgen Inc
NASDAQ:AMGN
140.6B USD 4.3 33.4 16 30.2
US
Gilead Sciences Inc
NASDAQ:GILD
115.7B USD 4.1 920.7 10.2 10.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.9B USD 9.9 -218.6 21.3 22.4
US
Epizyme Inc
F:EPE
94.1B EUR 1 847 -471.3 -513.3 -499.6
AU
CSL Ltd
ASX:CSL
135.7B AUD 5.7 32.1 19.9 24.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.8B USD 5.6 16.8 15.2 16.9
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.6 -52.9
NL
argenx SE
XBRU:ARGX
36B EUR 19.3 -135.3 -109.3 -79.6
P/S Multiple
Revenue Growth P/S to Growth
SE
Biogaia AB
STO:BIOG B
Average P/S: 3 467 700.9
8.2
41%
0.2
FR
Pharnext SCA
OTC:PNEXF
38 142 781.8
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.7
20%
0.3
US
Amgen Inc
NASDAQ:AMGN
4.3
26%
0.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.1
10%
0.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.9
34%
0.3
US
E
Epizyme Inc
F:EPE
1 847
N/A N/A
AU
CSL Ltd
ASX:CSL
5.7
23%
0.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.6
23%
0.2
US
S
Seagen Inc
F:SGT
17.8
118%
0.2
NL
argenx SE
XBRU:ARGX
19.3
220%
0.1
P/E Multiple
Earnings Growth P/E to Growth
SE
Biogaia AB
STO:BIOG B
Average P/E: 183
33.1
37%
0.9
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 287 N/A N/A
US
Abbvie Inc
NYSE:ABBV
62.1
413%
0.2
US
Amgen Inc
NASDAQ:AMGN
33.4
73%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
920.7
77%
11.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -218.6
48%
N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -471.3 N/A N/A
AU
CSL Ltd
ASX:CSL
32.1
65%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.8
44%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -135.3 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SE
Biogaia AB
STO:BIOG B
Average EV/EBITDA: 17
21
40%
0.5
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -220 140.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.4
29%
0.5
US
Amgen Inc
NASDAQ:AMGN
16
62%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
16%
0.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
21.3
43%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -513.3 N/A N/A
AU
CSL Ltd
ASX:CSL
19.9
42%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.2
35%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.6 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -109.3 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
SE
Biogaia AB
STO:BIOG B
Average EV/EBIT: 21.9
25.1
41%
0.6
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 628.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.7
90%
0.3
US
Amgen Inc
NASDAQ:AMGN
30.2
90%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
32%
0.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.4
45%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -499.6 N/A N/A
AU
CSL Ltd
ASX:CSL
24.8
54%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.9
42%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -52.9 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -79.6 N/A N/A

See Also

Discover More
Back to Top